SELF MADE AGE
DEAD

Serial Number

99078244

Owner

Cosmica Inc

Attorney

Peter Jensen-Haxel

Filing Date

Mar 11, 2025

Add to watchlist:

No watchlists yet
View on USPTO

SELF MADE AGE Trademark

Serial Number: 99078244

SELF MADE AGE is a trademark filed by Cosmica Inc on March 11, 2025. The trademark is classified under Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently no longer active.

Owner Contact Info

Cosmica Inc (4 trademarks)

[email protected]
San Francisco, CA 94107

Entity Type: 03

Trademark Details

Filing Date

March 11, 2025

Registration Date

Not Registered

Goods & Services

Pharmaceutical research and development; Scientific study and research in the field(s) of anti-aging products, ingredients and procedures; Technology consultation in the field of selecting anti-aging strategies, pharmaceuticals ,and cosmetics for anti-aging treatments suitable for their intended uses; Scientific research; Biological research; Biotechnology research; Medical and scientific research information in the field of pharmaceuticals and anti-aging treatments; Technology advisory services related to developing personalized intake protocols tailored to individual longevity goals; Scientific and technological services, namely, research and design in the field of aging, hallmarks of aging, low gravity exposure, cellular senescence, fibrosis, inflammation, cytokine production, immunosenescence, cytoskeleton, oxidative stress, and mitochondrial dysfunction

Nutraceuticals for use as a dietary supplement; Nutritional supplements; Dietary food supplements; Dietary and nutritional supplements; Powdered nutritional supplement drink mix and concentrate; Nutritional supplements in the form of capsules, tablets, caplets, powder, and syrups; Nutraceuticals for the treatment of aging-related diseases; Nutritional supplements for anti-aging; Nutritional supplements for inflammation reduction; Nutritional supplements for dietary adjustment, amendment, and supplementation for anti-aging; Nutritional supplements for custom dietary supplement protocols for individuals for anti-aging; Nutritional supplements for helping alleviate low gravity exposure, cellular senescence, fibrosis, inflammation, cytokine production, immunosenescence, cytoskeleton stress, oxidative stress, and mitochondrial dysfunction; Pharmaceutical preparations for anti-aging; Pharmaceutical preparations for inflammation reduction; Pharmaceutical preparations for the treatment of low gravity exposure, cellular senescence, fibrosis, inflammation, cytokine production, immunosenescence, cytoskeleton stress, oxidative stress, and mitochondrial dysfunction

Home health care services, namely, anti-aging therapy; Medical clinics; Medical services, namely, anti-aging therapy; Medical services, namely, diagnostics for aging therapy; Medical services, namely, metabolic assessments to determine personalized consumption requirements; Medical services, namely, providing guidance on intake modifications and enhancements aimed at promoting healthy aging; Medical services, namely, providing recommendations on strategies to support the reduction of inflammation through targeted consumption; Medical services in the field of testing and developing custom exercise protocols for individuals for anti-aging; Medical services, namely, metabolic testing for anti- aging therapy; Providing personalized healthcare and medical information in the nature of recommendations on strategies to support the reduction of inflammation through targeted consumption; Providing personalized healthcare and medical information in the nature of testing and developing custom exercise protocols for individuals for anti-aging; Providing personalized healthcare and medical information in the nature of anti-aging medicine, namely, nutrition counseling and anti-aging therapy; Medical services, namely, medical testing and therapy in the field of aging, low gravity exposure, cellular senescence, fibrosis, inflammation, cytokine production, immunosenescence, cytoskeleton, oxidative stress, and mitochondrial dysfunction

Filing History

ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
Nov 28, 2025 MAB2
ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Nov 28, 2025 ABN2
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Aug 12, 2025 GNRN
NON-FINAL ACTION E-MAILED
Aug 12, 2025 GNRT
NON-FINAL ACTION WRITTEN
Aug 12, 2025 CNRT
ASSIGNED TO EXAMINER
Aug 8, 2025 DOCK
APPLICATION FILING RECEIPT MAILED
Mar 11, 2025 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Mar 11, 2025 NWOS
NEW APPLICATION ENTERED
Mar 11, 2025 NWAP